此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Preoperative Venous Collapsibility Indices and Post-Induction Hypotension in Patients Undergoing Elective Isolated Coronary Artery Bypass Grafting

2026年11月12日 更新者:Gozde Altun、Istanbul University - Cerrahpasa

Association Between Preoperative Venous Collapsibility Indices and Post-Induction Hypotension in Patients Undergoing Elective Isolated Coronary Artery Bypass Grafting: A Prospective Observational Study

This study will examine whether changes in the size of three large veins during normal breathing are associated with low blood pressure shortly after general anaesthesia begins in adults scheduled for planned coronary artery bypass surgery.

Before anaesthesia, a researcher will use ultrasound to measure how much the three veins narrow and widen as each participant breathes normally. The research team will then monitor blood pressure during the first 10 minutes after anaesthesia begins. The study hypothesis is that the amount of change in vein size is associated with the likelihood of low blood pressure during this period. The team will compare how well the three measurements distinguish between participants who develop low blood pressure and those who do not. The ultrasound results will not be used to guide anaesthesia or treatment.

研究概览

详细说明

This single-centre, prospective observational cohort study will be conducted at the Institute of Cardiology, Istanbul University-Cerrahpasa. Adults scheduled for elective isolated coronary artery bypass grafting will be enrolled consecutively.

A single investigator will perform all ultrasound examinations before any sedative or anaesthetic medication is administered. Participants will lie supine with the head in a neutral position and breathe quietly without assistance. The right internal jugular vein, right subclavian vein and inferior vena cava will be assessed in each participant. For each vein, the maximum and minimum internal anteroposterior diameters will be measured using M-mode ultrasound over three separate respiratory cycles. The collapsibility index for each cycle will be calculated by subtracting the minimum diameter from the maximum diameter, dividing the difference by the maximum diameter and multiplying by 100. The mean of the three cycle-specific indices will be used for each vein. The vein and the reason for any technically inadequate measurement will be recorded.

Invasive arterial pressure will be monitored continuously during the observation period. Baseline mean arterial pressure will be calculated as the average of three stable readings obtained one minute apart before any sedative or anaesthetic medication is administered. The start of intravenous fentanyl administration will mark the start of induction and the beginning of the 10-minute observation period. The anaesthetist performing induction will be unaware of the ultrasound results. The attending anaesthetist will determine perioperative management and treatment according to clinical judgement.

The association between each venous collapsibility index and post-induction hypotension will be assessed in a separate logistic regression model. Discrimination will be evaluated using the area under the receiver operating characteristic curve. The three areas will be compared using the paired DeLong test in participants with valid measurements for all three veins.

研究类型

观察性的

注册 (估计的)

102

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

The study population will consist of adults scheduled for elective isolated coronary artery bypass grafting at the Institute of Cardiology, Istanbul University-Cerrahpaşa, Istanbul, Türkiye. Patients will be screened consecutively during the study period. Those who meet the eligibility criteria and provide written informed consent will be enrolled.

描述

Inclusion Criteria:

  • Age 18 years or older.
  • Scheduled for elective isolated coronary artery bypass grafting.
  • Provides written informed consent.

Exclusion Criteria:

  • Urgent or emergency surgery.
  • Planned concomitant cardiac surgery in addition to coronary artery bypass grafting.
  • Left ventricular ejection fraction below 40% on preoperative transthoracic echocardiography.
  • Tricuspid annular plane systolic excursion (TAPSE) of 17 mm or less, or severe right ventricular systolic dysfunction on preoperative echocardiographic assessment.
  • Severe or greater tricuspid regurgitation.
  • Haemodynamic instability requiring vasopressor or inotropic support before induction of anaesthesia.
  • Known thrombosis in a vein selected for ultrasound assessment or an indwelling catheter that interferes with the planned measurement.
  • Inability to assume the position required for venous ultrasonography.
  • No reliable ultrasound measurements can be obtained from the three target veins during quiet spontaneous breathing.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
Adults Undergoing Elective Isolated Coronary Artery Bypass Grafting

Adults scheduled for elective isolated coronary artery bypass grafting will undergo venous ultrasound before induction of general anaesthesia. Collapsibility indices will be measured in the right internal jugular vein, right subclavian vein and inferior vena cava during quiet spontaneous breathing. Participants will be observed for hypotension during the first 10 minutes after induction begins. The ultrasound findings will be used for research analysis.

Bedside M-mode ultrasonography will be performed before administration of any sedative or anaesthetic medication. The collapsibility index for each vein will be calculated from diameter changes during three quiet spontaneous respiratory cycles. The ultrasound findings will not be used to guide anaesthesia or treatment.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Proportion of Participants With Post-Induction Hypotension
大体时间:Within the first 10 minutes from the start of intravenous fentanyl administration for induction of general anaesthesia.

Proportion of participants who experience at least one episode of hypotension during the first 10 minutes after induction of general anaesthesia begins. Hypotension is defined as a mean arterial pressure (MAP) below 65 mmHg or a decrease of more than 20% from baseline MAP. Baseline MAP is the mean of three stable invasive arterial pressure readings taken one minute apart before administration of any sedative or anaesthetic medication. Arterial pressure will be monitored continuously. After measurement artefacts have been excluded, any episode meeting either criterion will count, including episodes that resolve rapidly after treatment.

Within the first 10 minutes from the start of intravenous fentanyl administration for induction of general anaesthesia.

次要结果测量

结果测量
措施说明
大体时间
Lowest Mean Arterial Pressure
大体时间:During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.

Lowest artefact-free mean arterial pressure (MAP), in mmHg, recorded by continuous invasive arterial pressure monitoring during the observation period.

During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
Maximum Absolute Decrease in Mean Arterial Pressure
大体时间:During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.

Baseline mean arterial pressure (MAP) minus the lowest artefact-free MAP recorded during the observation period, expressed in mmHg.

During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
Maximum Percentage Decrease in Mean Arterial Pressure
大体时间:During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.

Baseline mean arterial pressure (MAP) minus the lowest artefact-free MAP recorded during the observation period, divided by baseline MAP and multiplied by 100.

During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
Proportion of Participants Requiring Vasopressors for Hypotension
大体时间:During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.

Proportion of participants who receive at least one vasopressor dose to treat hypotension during the observation period. The agent, dose and administration time will be recorded for each administration.

During the first 10 minutes after the start of intravenous fentanyl administration for induction of general anaesthesia.
Discrimination of Post-Induction Hypotension by Pre-Induction Venous Collapsibility Indices
大体时间:Venous indices measured before induction of general anaesthesia. Hypotension assessed within the first 10 minutes from the start of intravenous fentanyl administration for induction.

The area under the receiver operating characteristic curve (AUC) and its 95% confidence interval will be estimated for each pre-induction venous collapsibility index (internal jugular vein, subclavian vein and inferior vena cava) to assess discrimination of post-induction hypotension. AUCs will be compared using the paired DeLong test in participants with valid measurements for all three indices.

Venous indices measured before induction of general anaesthesia. Hypotension assessed within the first 10 minutes from the start of intravenous fentanyl administration for induction.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年12月10日

初级完成 (估计的)

2027年5月10日

研究完成 (估计的)

2027年6月10日

研究注册日期

首次提交

2026年11月12日

首先提交符合 QC 标准的

2026年11月12日

首次发布 (实际的)

2026年11月18日

研究记录更新

最后更新发布 (实际的)

2026年11月18日

上次提交的符合 QC 标准的更新

2026年11月12日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

There is no current plan to share individual participant data with other researchers.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅